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M13 is a filamentous bacteriophage with a 6 nm thick and 1 µm length tubular structure. Approximately, 3000 subunits 
of PVIII, the major coat protein form a cylinder that encapsulates the M13 single-stranded DNA genome. Among capsid 
proteins sequences, PVIII gene is particularly amenable for the expression of recombinant peptides on the phage surface. It 
has been identified that thiol rich peptides are able to interact with heavy metals. In this work, we incorporated a heavy 
metal binding peptide to PVIII producing a viral particle capable of interacting with cadmium. For this purpose, we designed 
a chimeric gene composed of the coding sequence of a cysteine rich peptide linked to PVIII and cloned into a phagemid 
vector. Then, we established the optimal conditions for phage production by regulating the expression of the chimeric PVIII 
protein by using an isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible system. The cysteine rich recombinant phage 
interacted with cadmium in a highly efficient manner. Considering this novel property, the recombinant phage produced in 
this work could be used as a nanotechnology tool in the development of affinity columns, concentration systems for 
cadmium analysis or bioremediation.  
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Introduction 
Cadmium is considered the metal of the 20th 
century. Unlike other metals such as lead and mercury, 
which have been used since ancient times, its use 
started more recently, in such a way that 65% of 
cumulative world production took place in recent 
decades1. At present, cadmium is mainly used in the 
manufacture of nickel-cadmium batteries, pigments, 
special alloys and plastic stabilizers such as polyvinyl 
chloride, whereas its use in common alloys, welding 
and electroplating show a downward trend. The 
refining and use of cadmium, copper and nickel 
smelting, and the burning of fossil fuels are 
anthropogenic activities that release 3 to 10 folds more 
cadmium into the environment than natural sources2. 
The effects of cadmium on human health has been 
extensively studied and include lung damage, 
accumulation in the liver and especially in the kidneys 
and bones, gastrointestinal irritation, vomiting, 
diarrhea, bone weakness, anemia, eosinophilia, 
chronic rhinitis, irreversible renal damage and death. 
In addition to these effects, cadmium is a potent 
human carcinogen associated with cancer of the lung, 
prostate, bladder, pancreas, kidneys and liver2-3. 
The World Health Organization (WHO), in 
association with the Food and Drug Administration 
(FDA), and institutions in several countries are 
seeking to establish guidelines to limit levels of 
exposure to cadmium to minimize the occurrence of 
its toxic effects. However, these effects are still 
reported, therefore, methodologies to reduce the 
levels of cadmium in the environment, or to facilitate 
their detection are required1,3-4. 
New technologies are available for the 
development of innovative tools that could provide 
practical solutions to complex problems such as 
cadmium pollution. The technology of exposure 
peptides in bacteriophages or phage display, is a 
technique that has evolved to allow the production of 
nanoparticles that can bind and detect specific 
molecules5–7.  
It’s well known that the thiol groups from cysteines 
can interact with heavy metals. Because of this, 
cysteine rich peptides that interact with heavy metals, 
and in particular with cadmium, have been isolated8. 
——— 
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Different biosorption systems have been designed by 
expressing these peptides on the surface of bacteria 
and yeasts9–11. Bacteriophages are viruses that infect 
bacterial cells and are widely used as molecular 
biology tools. In 1985, George P. Smith displayed 
foreign peptides on the virion surface by inserting 
foreign DNA fragments into the filamentous phage 
gene III12, demonstrating that foreign peptides could 
be introduced and expressed on the virion surface in a 
functional form. Since then, phage display technology 
allows the use of phages for several applications from 
protein engineering to biomaterial development. 
Nowadays, filamentous phages are used as genetically 
modified nanometric building blocks, for the 
development of new materials with different forms, 
shapes and levels of organizations13–15.  
Using this technology, it was possible to  
generate biomedical16–18, optical19-20, electrical21-22, 
electrochemical23-24, electronic13,25 and other biotech 
nological devices6,22; including phages capable of 
interacting with different entities, such as metals25–27, 
nanoparticles14,28-29 and others30-31. 
M13 has a tubular structure with a 6.5 nm of 
diameter with a variable length depending on the 
genome size12. Approximately 2800 copies of PVIII 
protein stacked in a helical array compose the core of 
the viral particle. One end of the particle contains 
copies of PIII and PVI proteins, and the other end 
contains PIX and PVII proteins (Figure 1A). Genetic 
engineering allows the generation of phages with 
affinity for different ligands. Frequently they are 
obtained by fusing a foreign peptide to PVIII, its high 
copy number in the viral particle allows the display of 
a large amount of recombinant protein per phage 
particle32. Also, it is possible to modify PIII to 
incorporate a foreign peptides of up to 50 amino 
acids, but, since there are only three copies of this 
protein in the virion, these peptides are displayed in a 
low valency33. Proteins PVII and PIX can also be 
modified, however, due to the limited number of 
copies in the virion and the restricted length of 
peptides that can be inserted into their genes, they are 
not used as often as PIII and PVIII34. 
In this work, we designed, constructed and 
successfully produced a recombinant bacteriophage 
displaying a cysteine rich peptide on PVIII that is able to 
bind cadmium. This phage could be used in several 
applications such as analytical detection and in metal 
biocaptation from complex systems, generating a 
potential novel use of nanotechnology in bioremediation. 
Materials and Methods 
Recombinant Phage Construction 
For the construction of the cadmium binding phage 
(M13-CBP), a synthetic sequence was designed in 
silico using the Gene Designer software35 and 
synthesized by the gBlocks® Gene Fragments service 
(Integrated DNA Technologies). This sequence 
included a promoter, a regulatory sequence and 
cadmium binding peptide sequence fused to the PVIII 
gene (Fig. 1C). A 20 ng of gBlock were amplified by 
PCR reaction containing 0.5 μL Platinum® Pfx DNA 
polymerase (Invitrogen), 2.5 μL of 10X Pfx 
amplification buffer, 2.5 μL of 10X enhancer solution, 
0.5 μl of 50 mM magnesium sulphate, 0.75 μL of 
dNTPs solution (Promega), 1 μl of each primer 
(forward Fw-PF-PVIII-Cd, reverse Rv-PVIII-Cd) and 
nuclease-free water to 25 μl. Amplification was 
carried out with the following parameters: 5 min at 
 
Fig. 1 — A) Schematic representation of M13 filamentous 
bacteriophage. The circular genome is covered by a protein 
structure made by the major structural protein PVIII, and others 
minor proteins including PIII, PVI, PVII & PIX, B) Schematic 
representation of recombinant M13 bacteriophage (M13-CBP). 
The bold circles represent the cadmium binding peptide (CBP), 
and its DNA and protein sequences are shown and C. Schematic 
representation of the synthetic sequence designed to produce the 
CBP-PVIII; p-Lac: Lac promoter; p-T7: T7 promoter; O-Lac: Lac 
operator; Leader: PVIII leader sequence; CBP: cadmium binding 
peptide; PVIII: PVIII gene. 
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94°C, 30 cycles of denaturation for 30 seconds at 94°C, 
annealing for 45 seconds at 50°C and extension for 45 
seconds at 68°C followed by 7 min at 68°C. The product 
was resolved in 1% agarose gels, purified using Wizard 
SV Gel and PCR clean-up system (Promega) and 
digested with the HindIII enzyme. Later, this product 
was cloned into HindIII site of the pFG phagemid vector 
and transformed into E. coli ER2738 (NEB). Clones 
were screened using restriction enzymes and PCR. 
 
Phage Production  
Transformed Escherichia coli ER2738 were 
cultured at 37°C in liquid Luria Bertani (LB) medium 
containing tetracycline and ampicillin, later infected 
with the helper phage M13KO7 and cultured in LB 
medium containing kanamycin. Bacteria were 
removed by centrifugation at 3500 g for 20 min, and 
the phages were precipitated from the supernatant 
with 3% NaCl and 4% PEG 8000. Finally, the virus 
was centrifuged at 15000 g for 30 min, and the phage 
pellet was resuspended in 1 mL of tris-buffered saline 
(TBS) buffer, pH 7.7 and filtered with 0.45 μm 
polyvinylidene difluoride (PVDF) membranes. The 
same process was carried out with the empty vector 
(without the CBP-PVIII peptide) to produce  
control virus.  
To titrate the phages, serial 10-fold dilutions were 
performed and mixed with E. coli ER2738. After 1 
hour of incubation without agitation, each dilution 
was platted on LB agar containing the corresponding 
antibiotic. After an overnight incubation at 37°C the 
resistant colonies were counted. 
 
Viral Proteins Analysis 
Thirty µL of the purified phage were resolved on 
15% polyacrylamide gels and stained with Coomassie 
blue. Afterwards, proteins present in the purified 
phage were quantified using the Bradford method. 
Additionally, PVIII protein was quantified through 
enzyme linked immunosorbent assay (ELISA). 
Briefly, maxisorp microplates (NUNC) were coated 
with 0.5 μg of phage in 100 mM NaHCO3/Na2CO3, 
pH 9.6 at 37°C for 2 hours. Plates were blocked with 
1% BSA in TBS, and incubated for 2 hours with 100 μl 
of horshradish peroxidase (HRP)-conjugated anti-
pVIII antibody (Merck) diluted 1:1000 in 1% 
BSA/TBS. At each step, plates were washed  
with 0.05% TBS-Tween 20. Antigen-antibody 
reaction was detected by addition of ABTS {2,2̍-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)}. 
After incubation for 20 min, the absorbance was 
measured at 405 nm with a microplate reader. 
 
IPTG Inducible System 
E. coli ER2738 bacteria containing the vector with 
the insert (pFG-CBP-PVIII) were transformed with the 
pET28b vector which contains the lacI gene, and 
selected in a medium with ampicillin and kanamycin. 
This allows the regulation of CBP-PVIII expression 
with IPTG. The transformed bacteria, were inoculated 
in 10 mL of LB medium containing ampicillin and 
kanamycin and incubated at 37°C until OD600 = 0.5. 
Later, different amounts of IPTG were added, whereas 
an uninduced culture was used as control. The cells 
were infected with M13KO7 helper phage and the 
entire volume was transferred to 200 mL LB medium 
with ampicillin/kanamycin and the corresponding 
IPTG. After an overnight incubation at 37°C, the 
phages were precipitated as previously explained.  
 
Cadmium Binding Assay 
To evaluate the cadmium binding capacity of 
phages, 4 × 108 cfu. were incubated with a solution of 
1 mg of Cd (as sulfate salt) overnight at room 
temperature with agitation at 250 rpm. The phage was 
purified from the supernantant by the PEG/NaCl 
precipitation method. For that, the solution was 
centrifuged and the phage was purified from the 
supernatant with the addition of 1/6 volume of 20% 
PEG 8000/2.5 M NaCl and incubated on ice for  
5 hours. Then, it was centrifuged and the precipitate 
phage was resuspended in TBS (pH 7.7). 
In order to purify the cadmium bound to the phage, 
we introduced the pellet in crucibles and dried on a 
heating plate with a gradual increase of temperature 
from 70 to 320°C. Once dried, the residues were taken 
to the muffle furnace and incubated overnight at a 
temperature of 550°C for the carbonization of organic 
residues. Subsequently, 4 drops of distilled water and 
4 drops of 1:1 nitric acid/water solution were added to 
the plate and the drying process was repeated until 
complete evaporation. Then the plate was 
reintroduced into the muffle furnace for 2 hours. 
Finally, 1 mL of 3 N HCl was added to the crucible 
and heated on the plate for a few min, and the solution 
was Whatman filtrated with paper (Whatman 1235) in 
10 mL volumetric flasks and the reaction was 
quenched with distilled water. 
The absorbance of the samples was measured with 
the atomic absorption spectrophotometer (Shimadzu 
AA6300) and the amount of cadmium in the sample 
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was calculated using a calibration curve with points 
corresponding to known concentrations of cadmium 
solutions. The assay was performed in triplicate, using 
TBS (pH 7.7) or phages without the CBP-PVIII  
as control. 
 
Results and Discussion 
Design and Production of Recombinant Bacteriophages 
It is well known that cysteine interacts with heavy 
metals, for this reason we decided to incorporate a 
cysteine rich peptide in a filamentous phage. We 
designed a PVIII fusion protein that was linked to a 
cysteine-rich peptide, which has previously been 
reported as a sequence capable of interacting with 
cadmium8-9 (Fig. 1B). To construct the phage, we 
designed a polyfunctional sequence of DNA, 
encoding the cadmium binding peptide (CBP)  
PVIII, and included all the elements required for the 
expression of the recombinant PVIII protein (Fig. 1C), 
and the sequence was cloned into a phagemid vector. 
We used this vector to produce the recombinant 
phage (M13-CBP), and the amount of phage was 
calculated based on the number of ampicillin-resistant 
bacterial colonies, obtained after phage infection. As 
is shown in Figure 2A, less amount of infective 
recombinant phages M13-CBP were produced in 
comparision with the phage without CBP. Since this 
method only quantifies the infective phages, we 
decided to analyze the total amount of phage. To that 
end, we analyzed the protein content present in the 
purified phage by SDS-PAGE. As can be seen in 
Figure 2B, a decrease in the total amount of M13-
CBP phage was observed in comparison with the 
phage without CBP. The observed difference in total 
phage-protein levels shown in Figure 2B is even more 
striking in the 5 kDa band, which corresponds to the 
phage PVIII protein. It is important to mention that no 
difference was found in CBP-PVIII migration 
compared to wild type PVIII. This is not an 
unexpected result, since the CBP has only 9 amino 
acids. The decrease in phage production was 
confirmed by quantifying the total amount of PVIII 
through ELISA (Fig. 2C). 
It has been shown that foreign peptides coupled to 
PVIII could decrease phage production. In agreement 
with our results, a previous report showed that 
cysteine peptides are less present in infective phages 
compared to the random peptides sequences used to 
construct a PVIII phage display library36. This could 
be due to the ability of cysteines to form intra- or 
inter-disulfide bridges; it is noteworthy that phages 
are assembled in the periplasmic region, which favors 
the formation of disulfide bridges. A high expression 
of CBP-PVIII protein is expected since it is under the 
control of the lac promoter. To regulate the expression 
of this protein, we took advantage of the presence of 
the lac operator in the promoter that controls the 
 
 
Fig. 2 — CBP decrease recombinant virus production. A) 
Infective phage production in the presence or absence of CBP, 
quantified by measurement of colony forming units, B) Phages 
proteins resolved on acrylamide gels and stained with Coomassie 
blue in the presence or absence of CBP and C) PVIII levels in 
purified phage produced in the presence or absence of CBP, 
quantified by ELISA. No/pept: corresponds to the phage without 
CBP. CBP corresponds to the recombinant phage with CBP-
PVIII; KO7 corresponds to helper phage. cfu.: colony forming 
units. MW: Molecular weight marker. ***p<0.001 
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expression of CBP-PVIII. In the presence of the lacI 
protein, the promoter is inactive and CBP-PVIII is not 
expressed; however in the presence of the IPTG 
inducer, the lacI inhibitory protein is detached from 
the promoter and this activates the expression of 
CBP-PVIII. Using this system, it was possible to 
regulate the expression levels of the recombinant 
protein during viral production. Phage production was 
evaluated at different IPTG concentrations. At high 
concentrations of IPTG, little phage production was 
observed, probably due to the inhibitory presence  
of CBP-PVIII (Fig. 3). However, at lower concentrations 
such as 0.5 mM of IPTG, a higher phage production 
was observed (Fig. 3B). In conclusion, CBP-PVIII 
has an inhibitory effect on phage production, and  
this effect could be overcome by regulating its 
expression. 
 
Binding of the Bacteriophage M13-Cd to the Metal Cadmium 
Having established conditions to produce the M13-
CBP phage, we tested its ability to bind cadmium. For 
this purpose, phages with or without CBP were 
incubated with cadmium in TBS buffer. After 
incubations, the phages were precipitated and the 
pellets and analyzed by atomic absorption 
spectrophotometry. As shown in Figure 4, the phages 
with CBP were able to interact with cadmium, unlike 
the phages without the peptide, where the value of 
absorbance was below the sensitivity limit of this 
technique. It has been previously published that CBP 
is capable of interacting with cadmium. This peptide 
was designed according to the amino acid 
composition of metal binding sites of zinc finger 
peptides. It is noteworthy that CBP could interact with 
other heavy metals like copper and zinc, but with less 
affinity. The CBP peptide has been incorporated into 
different organism like bacterial cells and yeast to 
biosorb cadmium. Considering the characteristics of 
the designed phage, it is expected that the number of 
copies of the peptides per viral particle will be greater 
than that of the bacteria or yeast transporters of the 
peptide. In cadmium-saturated conditions, 4 x 108 
recombinant viral particles were able to biosorb  
8.02 ± 0.3 μg of cadmium (Fig. 4). Since a phage has 
a molecular weight of 1.1 x 107 Da37, 1.106μg of 
cadmium could be adsorbed per mg of the 
recombinant phage; indicating that 1.26 x 106 
cadmium ions were adsorbed per viral particle. This 
number is higher than the number of copies of PVIII 
present in the phage particle, hence this result 
suggests the existence of polyvalent joints, or the 
entrainment of ions by the formation of interaction 
networks between the particle and cadmium. 
Phage display achieved through the exposure of 
random peptides on the surface of phages, allowing 
the selection of specific nanoparticles capable of 
binding many types of inorganic materials, among 
which there are aluminum, sphalerite, chalcopyrite, 
and a number of minerals38–40. This introduces novel 
techniques for biomining, separation of minerals from 
waste, improving recovery of fine minerals lost in 
 
Fig. 3 — Regulation of CBP-PVIII expression increased phage
production. A) Total protein levels in purified bacteriophages 
after induction with IPTG, and B) Phages proteins resolved on 
acrylamide gels and stained with Coomassie blue at different 
concentrations of IPTG and C) Phages production in the presence
0.5 mM of IPTG. no/Ind: uninduced bacteria. cfu. colony forming 
units. MW: Molecular weight marker. ***p < 0.001. 
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wastewater and refining wastewater treatment  
in bioremediation. Also, filamentous phages has  
been used to obtain different nanomolecular structures 
like tubes, nanowires, sheets and rods converting  
this phages in a verstile tool for nanomaterials  
production. 
Similarly, other structural proteins, such as PIII, 
could be modified to incorporate peptides that allow 
their interaction with different matrices and facilitates 
their use as an analytical or bioremediation tool.  
 
Conclusions 
In the present work, we generated a recombinant 
M13 phage capable of binding cadmium by inserting 
a cysteine-rich sequence upstream of the PVIII 
protein. The presence of the cysteine-rich peptide 
fused to PVIII affected the assembly and production 
of recombinant bacteriophages, which was solved by 
the implementation of an IPTG-inducible system.  
The recombinant bacteriophage can be used as a 
biotechnological tool, either in the analytical area, as 
a bioremediation system or in other applications that 
can take advantage of this binding property. 
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